New Delhi, March 17 (IANS) Aurobindo Pharma on Tuesday said that the US Food and Drug Administration (USFDA) has classified one of its subsidiary units as “Official Action Indicated” (OAI) following an inspection conducted last year.In a regulatory filing, the company said that the USFDA inspected Unit-II of Eugia Pharma Specialities Limited, its wholly-owned subsidiary, located in Bhiwadi, Rajasthan, between November 3 and 14, 2025.At the end of the inspection, the regulator had issued a Fo…
Trending
- Mathe Male Hoyyuthide Review: A Heartfelt Generational Love Story Set in the Rains of Malenadu
- M4M – Motive for Murder Review: A Gripping Telugu Crime Thriller That Turns Murders into Masterpieces
- Ankam Attahasam Movie Review (2026): Madhav Suresh’s Gritty Trivandrum Gangster Drama Is a Raw, Riveting Ride
- Citadel Season 2 Review (2026): Priyanka Chopra, Richard Madden & Stanley Tucci Make This Prime Video Thriller Unmissable
- Dridam Movie Review: Shane Nigam’s Slow-Burn Cop Drama Is Gripping — Until It Isn’t
- 29 Movie Review: A Heartfelt Romantic Drama That Blooms in Its Own Time
- Razor Movie Review (2026): Ravi Babu Delivers a Gripping Survival Thriller
- Sathi Leelavathi Review (2026): Lavanya Tripathi Shines in This Heartfelt Family Entertainer